Regulatory
FDA Rewrites Its Rules to Make Room for Alternatives to Animal Testing
A new rule swaps the term “animal tests” for “nonclinical tests,” formally recognizing lab-on-a-chip, human-cell and AI methods as valid ways to gauge a drug’s safety — without banning animal studies.